Influence of the Timing of Antiretroviral Therapy on the Potential for Normalization of Immune Status in Human Immunodeficiency Virus 1–Infected Individuals
Jason F. Okulicz(Gilead Sciences (United States)), Sunil K. Ahuja(South Texas Veterans Health Care System), Edwina Wright, Susan J. Little(University of California San Diego), Tuan Le(University of Colorado Hospital), José F. Camargo(University of Miami), Davey M. Smith(University of San Diego), Matthew J. Dolan(The University of Melbourne), Douglas D. Richman(University of San Diego), Robert A. Clark(The University of Texas at San Antonio Health Science Center), Michael L. Landrum(San Antonio Military Medical Center), Anuradha Ganesan(Walter Reed National Military Medical Center), Brian K. Agan(Henry M. Jackson Foundation), Tomas M. Ferguson, Weijing He
Cited by 84
Related Papers
Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy
|Science|1997|3.1k
The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex
|New England Journal of Medicine|1987|3k
Antiretroviral Treatment of Adult HIV Infection
|JAMA|2012|2.5k
Recovery of Replication-Competent HIV Despite Prolonged Suppression of Plasma Viremia
|Science|1997|2.2k
Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy
|New England Journal of Medicine|1997|1.9k